EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Accuracy of ctDNA-based minimal residual disease detection in predicting postoperative recurrence of breast cancer: a meta-analysis

Hang You, JiuJiang He, Tian Tian

Frontiers in Oncology · 03.02.2026 · 16

DOI: 10.3389/fonc.2026.1735752 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Oncology, online erschienen am 03.02.2026. Verfasst von Hang You und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The Affiliated Yongchuan Hospital of Chongqing Medical University, Chongqing, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Detection of circulating tumor DNA (ctDNA) has attracted growing attention for predicting postoperative breast cancer recurrence; however, the differences between the landmark and surveillance strategies remain unclear.

Methods

We systematically searched the PubMed, Cochrane Library, Embase, and Ovid MEDLINE databases for studies published up to April 17, 2025. Effect models were selected based on heterogeneity tests to pool diagnostic indicators, including sensitivity and specificity. Subgroup analyses were conducted according to molecular subtype, detection method, analytical strategy, and disease stage.

Results

A total of 17 studies were included in the analysis. The sensitivity and specificity of the landmark strategy were 0.40 (95% CI: 0.22–0.62) and 0.95 (95% CI: 0.81–0.99), respectively. For the surveillance strategy, sensitivity was 0.79 (95% CI: 0.71–0.85) and specificity was 0.98 (95% CI: 0.92–0.99). The surveillance strategy significantly improved sensitivity without a substantial loss of specificity. Among molecular subtypes, triple-negative breast cancer(TNBC) exhibited the best performance under the surveillance strategy. Whole-genome sequencing (WGS), droplet digital PCR (ddPCR), and whole-exome sequencing (WES) all demonstrated high sensitivity within the surveillance framework. Conclusion ctDNA serves as a highly specific biomarker for predicting postoperative breast cancer recurrence. The surveillance strategy substantially improves its sensitivity; however, the current performance remains below the ideal threshold for clinical implementation. Future research should focus on refining detection strategies and technologies to achieve personalized recurrence risk stratification and guide therapeutic decision-making. Systematic Review Registration https://www.crd.york.ac.uk/prospero/ , identifier CRD420251056270.

Schlagwörter

Stichwörter der Autor:innen

breast cancercirculating tumor DNActDNAdiagnostic accuracymonitoring strategypostoperative recurrence

Autor:innen und Institutionen

  • Department of Breast Surgery, The Affiliated Yongchuan Hospital of Chongqing Medical University, Chongqing, China.

Zitieren

APA

You, H., He, J., & Tian, T. (2026). Accuracy of ctDNA-based minimal residual disease detection in predicting postoperative recurrence of breast cancer: a meta-analysis. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1735752

Vancouver

You H, He J, Tian T. Accuracy of ctDNA-based minimal residual disease detection in predicting postoperative recurrence of breast cancer: a meta-analysis. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1735752

BibTeX
@article{You2026,
  author = {You, Hang and He, JiuJiang and Tian, Tian},
  title = {Accuracy of ctDNA-based minimal residual disease detection in predicting postoperative recurrence of breast cancer: a meta-analysis},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1735752}
}
Kostenlos starten →